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ABSTRACT
Interferons (IFN) play a pivotal role in innate
immunity, orchestrating a cell-intrinsic anti-
pathogenic state and stimulating adaptive immune
responses. The complex interplay between the
primary response to IFNs and its modulation by
positive and negative feedback loops is incom-
pletely understood. Here, we implement the
combination of high-resolution gene-expression
profiling of nascent RNA with translational inhibition
of secondary feedback by cycloheximide.
Unexpectedly, this approach revealed a prominent
role of negative feedback mechanisms during the
immediate (60 min) IFNa response. In contrast, a
more complex picture involving both negative and
positive feedback loops was observed on IFNc treat-
ment. IFNc-induced repression of genes associated
with regulation of gene expression, cellular develop-
ment, apoptosis and cell growth resulted from
cycloheximide-resistant primary IFNc signalling.
In silico promoter analysis revealed significant
overrepresentation of SP1/SP3-binding sites and/
or GC-rich stretches. Although signal transducer
and activator of transcription 1 (STAT1)-binding
sites were not overrepresented, repression was
lost in absence of STAT1. Interestingly, basal ex-
pression of the majority of these IFNc-repressed
genes was dependent on STAT1 in IFN-naı¨ve fibro-
blasts. Finally, IFNc-mediated repression was also
found to be evident in primary murine macrophages.
IFN-repressed genes include negative regulators of
innate and stress response, and their decrease may
thus aid the establishment of a signalling perceptive
milieu.
INTRODUCTION
Interferons (IFNs) are soluble factors secreted on infec-
tion and capable of interfering (hence the name) with viral
replication (1). IFNs lack direct intrinsic anti-viral
capabilities and solely act as cytokines in an autocrine
and paracrine manner initiating a global anti-infective
change in the gene expression proﬁle. IFNs induce many
genes that are detrimental to cell survival and cell prolif-
eration so that the expression of IFN-stimulated genes
(ISGs) has to be prevented under ‘healthy’ or ‘uninfected’
conditions. On pathogen encounter, a robust defensive
state is rapidly initiated to outpace microbial gene expres-
sion and replication. Owing to this binary nature,
alternating between almost complete shut-off and rapid
induction, IFNs have frequently been used as a model
system to study stimulus-induced gene expression changes.
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Human individuals with pathologic mutations within
components of the IFN induction or signalling cascade
suffer from recurrent episodes of infectious diseases
elicited by opportunistic pathogens and frequently even
fail to control live attenuated vaccine strains (2–6).
Recombinant IFNs currently constitute the therapeutic
backbone of the treatment of hepatitis B virus and hepa-
titis C virus infections. IFNs are subdivided into three
classes: Type I IFN (IFNa/b), type II IFNs (IFNg) and
the recently identiﬁed type III IFNs (IFN), each being
deﬁned by a discrete receptor complex. Nevertheless, IFN-
signalling cascades converge in common pathways and
initiate gene expression almost exclusively via janus
kinase (JAK)/signal transducer and activator of transcrip-
tion (STAT)-signalling cascades (7). Type I IFNs (and
type III IFNs) mainly induce the formation of
STAT1:STAT2:IRF-9 heterotrimers [called IFN-
stimulated gene factor 3 (ISGF3)], whereas IFNg mainly
induces formation of STAT1 homodimers [called gamma-
activated factor (GAF)]. To a lesser extent, IFNg also
induces formation of ISGF3 complexes (8,9) and IFNa/
b also induces STAT1 homodimers (10). GAF and ISGF3
complexes translocate into the nucleus and bind to
gamma-activated sequences (GAS) and IFN-stimulated
response elements (ISRE), respectively, located in the
vicinity of promoters of ISGs, to recruit the transcrip-
tional machinery and facilitate gene expression.
Consensus sequences of ISRE and GAS elements are sig-
niﬁcantly different and can thus be easily distinguished on
DNA sequence level by bioinformatic means. Although
subtle differences concerning the preference for certain
sequence variations exist (11), basically all STAT family
members bind to GAS elements (core motif TTCN2-
4GAA). Therefore, it is not possible to deduce which
STAT protein binds to a particular GAS element in
natura based on its nucleotide sequence. ISRE elements
closely resemble interferon regulatory factor (IRF)-
binding sites (called IRF/E sites) confounding a
sequence-based differentiation of ISRE and IRF/E sites
(12,13).
IFNs themselves are subject to both positive and
negative feedback loops. On encountering a pathogen,
IFNb [and IFNa4 in the mouse—but not in humans
(14)] is expressed and signals through the JAK-STAT
pathway to induce the expression of further IFNa
subtypes, closing a self-amplifying loop (14,15).
Additionally, components of the IFN signal transduction
pathway, like STAT1 and STAT2, are themselves IFN
inducible (16). Conversely, a number of IFN-inducible
negative feedback mechanisms restrict IFN signal
transduction to prevent an excessive and potentially
detrimental hyper-activation of the innate immune
system (e.g. auto-immunity). Known mediators of this
counter regulation loop include suppressors of cyto-
kine signalling (SOCS) (17,18), ubiquitin speciﬁc peptid-
ase 18 (19) and protein inhibitors of activated STAT
proteins.
The currently accepted notion is that (especially on
IFNb encounter) the positive feedback constitutes an im-
portant and dominant event of IFN induction and
signalling [see for example (20)]. It is assumed that the
initial type I IFNs [IFNb (and IFNa4 in the mouse)]
stimulate the expression of gene products like the IFN-
inducing transcription factor IRF7, components of the
JAK-STAT signalling cascade (e.g. STAT1 and STAT2)
and secondary IFNa subtypes to mount an effective
innate immune response. Nevertheless, the regulation,
temporal contribution and hierarchy of positive and
negative feedback mechanisms to the IFN response are
incompletely investigated and understood.
Standard proﬁling of total RNA for the detection of
rapid changes in gene expression has a strong bias for
detecting upregulation of short-lived transcripts (21).
Therefore, the complex interaction network of positive
and negative regulators within the initial phase of IFN
signalling cannot be adequately studied by a sole assess-
ment of transcript changes in total RNA. This is especially
relevant for genes that are downregulated at the level of
transcription, as their overall change in total RNA is crit-
ically deﬁned by the intrinsic messenger RNA (mRNA)
decay rate. This problem can be overcome by metabolic
tagging, puriﬁcation and analysis of newly transcribed
RNA, using 4-thiouridine (4sU) (21,22). In this method,
4sU is incorporated in the newly transcribed RNA (4sU
tagging). Following isolation of total RNA and thiol-
speciﬁc biotinylation, newly transcribed RNA is separated
from untagged pre-existing RNA using streptavidin-
coated magnetic beads. All three RNA fractions (total
RNA, labelled RNA and unlabelled RNA) are suitable
for further analyses including quantitative PCR,
microarray analysis (21,22) or next-generation sequencing
(23–25).
In a previous study (21), we applied this approach to
study changes in gene expression mediated by type I and II
IFNs in murine ﬁbroblasts. Changes in transcription rates
were determined by Affymetrix arrays using newly
transcribed RNA, labelled and puriﬁed following 0–30,
30–60 and 150–180min of IFNa and IFNg treatment
(see Figure 1A for experimental setup). In newly
transcribed RNA, induction of a large number of ISGs
was already evident during the ﬁrst 30min of treatment.
However, in subsequent experiments, we found important
mediators of the positive feedback loop (e.g. IRF1) as well
as of the negative feedback loop (e.g. SOCS3), to be sub-
stantially induced already within the ﬁrst 15min of IFN
treatment. Thus, despite the 10-fold increase in sensitiv-
ity of our approach, primary (translation independent)
effects could not be differentiated from secondary (trans-
lation dependent).
Our previous study identiﬁed a network of genes re-
pressed by IFNg showing strong associations with regula-
tion of gene expression, cellular development, cell death,
cellular growth and proliferation (21). Without knowledge
of the underlying signal transduction mechanism, it had
remained unclear whether this response represents a direct
or an indirect effect of IFNg treatment. To address these
question and properly discriminate primary and second-
ary effects of type I and II IFNs, we now performed short-
term 4sU tagging during IFN treatment in presence and
absence of the translational inhibitor cycloheximide
(CHX).
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MATERIALS AND METHODS
Cell culture and 4sU tagging
Murine NIH-3T3 ﬁbroblasts (ATCC CRL1658) and
murine STAT1-/- ﬁbroblasts (26,27) were cultured in
Dulbecco’s modiﬁed Eagle’s medium supplemented with
5% (v/v) new-born calf serum. For 30min of metabolic
tagging of newly transcribed RNA, 4sU (Sigma) was
added to 500 mM ﬁnal concentration into pre-warmed
CO2-equilibrated medium. Cells were used only in
between 5th and 15th passage after thawing; split twice
weekly and 24 h before start of 4sU tagging. Total
cellular RNA was prepared from cells using Trizol
reagent (Invitrogen) following the protocol described by
Chomczynski and co-workers (28). In the CHX experi-
ments, NIH-3T3 cells were pre-treated with CHX
(50 mg/ml) for 15min before treatment with either mock,
100U/ml IFNa or IFNg for 60min. During the last
30min (=30–60min of IFN treatment), 4sU was added
at a ﬁnal concentration of 500 mM to the cell culture
medium (see Figure 1B). IFN activity and the effect of
CHX treatment was checked in parallel using the ISRE
Luc reporter cell line (9), which expresses luciferase under
an IFN-inducible promoter (data not shown).
Biotinylation and puriﬁcation of 4sU-labelled RNA
Separation of total RNA into 4sU-tagged newly
transcribed and untagged pre-existing RNA was
performed as described (21). Brieﬂy, biotinylation of
4sU-tagged RNA was performed using EZ-Link Biotin-
HPDP (Pierce) dissolved in dimethylformamide at a
concentration of 1mg/ml. It was crucial to avoid
dimethylformamide from getting in contact with incom-
patible plastic ware, as this may result in complete loss of
newly transcribed RNA during the streptavidin puriﬁca-
tion. Biotinylation was carried out in 10mM Tris (pH
7.4), 1mM EDTA and 0.2mg/ml Biotin-HPDP at a ﬁnal
RNA concentration of 100 ng/ml for 1.5 h at room tem-
perature. Unbound Biotin-HPDP was removed by chloro-
form/isoamylalcohol (24:1) extraction using Phase-lock-
gel (Heavy) tubes (Eppendorf). Afterwards, 1/10 volume
of 5M NaCl and an equal volume of isopropanol were
added and RNA was precipitated at 20 000g for 20min.
The pellet was washed with an equal volume of 75% (v/v)
ethanol and precipitated again at 20 000 g for 10min. The
pellet was re-suspended in 50–100 ml of RNase-free water.
After denaturation of RNA samples at 65C for 10min
followed by rapid cooling on ice for 5min, biotinylated
RNA was captured usingmMACS streptavidin beads and
columns (Miltenyi). Biotinylated RNA was incubated
with 100 ml of mMACS streptavidin beads with rotation
for 15min at room temperature. The beads were
transferred and magnetically ﬁxed to the columns.
Columns were washed three times with 1ml of 65C
washing buffer [100mM Tris–HCl (pH 7.4), 10mM
EDTA, 1M NaCl, 0.1% [vol/vol] Tween20] followed by
three washes with room temperature washing buffer.
Newly transcribed RNA was eluted from the beads by
the addition of 100ml of freshly prepared 100mM
dithiothreitol followed by a second elution round 5min
later. RNA was recovered using the RNeasy MinElute
kit (Qiagen).
Figure 1. Experimental setup. (A) Schematic overview of the experimental setup to assess IFN responses by microarray analysis using newly
transcribed and total RNA as published in (21). At different times of IFN treatment 4sU was added to cell culture medium for the indicated
periods indicated with black horizontal arrows. Total RNA was prepared immediately after the end of labelling and newly transcribed RNA was
puriﬁed and subjected to microarray analysis. (B) Schematic overview of the new experimental setup to test for the effect of translational inhibition
using CHX or mock (DMSO) on IFN-mediated differential gene expression CHX. Fifteen minutes before begin of IFN treatment, CHX pre-
treatment was started. Thirty minutes after begin of IFN treatment 4sU was added to cell culture medium to start RNA labelling. Thirty minutes
later (=60min of IFN treatment) total RNA was isolated and newly transcribed RNA was prepared. Three replicates of newly transcribed RNA
from each of the six conditions were subjected to microarray analysis. (C) Immunoblot analysis of the signal transduction events in NIH-3T3 cells on
incubation with IFNa (100 U/ml) and IFNg (100U/ml), respectively, in presence or absence of CHX (50 mg/ml). Cells were pre-treated for 15min
with CHX or DMSO (mock) and subsequently incubated for further 60min with the indicated IFN. Cells were lysed and lysates were subjected to
immunoblot analysis. Membranes were probed with the indicated antibodies.
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Microarray sample labelling, hybridization and
pre-processing
Total RNA (1.5 mg) or newly transcribed RNA (280 ng)
was ampliﬁed and labelled using the Affymetrix One-
Cycle Target Labelling Kit according to the manufac-
turer’s recommendations. Newly transcribed RNA
samples were ampliﬁed and labelled according to the
manufacturer’s protocol for mRNA. The ampliﬁed and
fragmented biotinylated cRNA was hybridized to
Affymetrix MG 430 2.0 arrays (mouse) using standard
procedures. The complete microarray data set is available
at Gene Expression Omnibus (GEO Series GSE30457).
Microarray data processing and statistical analysis for
analysis of IFN-mediated gene regulation
Data were processed and analysed using R and
Bioconductor (29,30). Data analysis of total RNA (1
and 3 h of IFN treatment) and newly transcribed RNA
samples (0–30, 30–60 and 150–180min of IFN treatment)
has been described in detail (21). The new microarray data
on 30–60min newly transcribed RNA (mock, IFNa,
IFNg;+/ CHX treatment) were processed independently
of the recently published data but following a similar
pipeline. Arrays were assessed for quality, ‘gene chip
robust multiarray averaging’ (gc-RMA) normalized,
ﬁltered for low expression and analysed using an empirical
Bayes moderated t-test.
‘Quality assessment’ consisted of RNA degradation
plots, Affymetrix quality control metrics, sample cross-
correlation, data distributions and probe-level
visualisations.
‘Normalization’ incorporated background correction,
normalization and probe-level summation by gc-RMA.
‘A non-speciﬁc ﬁlter’ in which all genes are retained that
were called ‘present’ in at least one sample in the data set
was applied before statistical testing (n=27 759 probes
passed this ﬁlter).
‘Statistical testing’ was performed by applying an em-
pirical Bayes moderated t-test (31), which is the most
robust test for small sample sizes. An increased rate of
false-positive results owing to simultaneous testing on a
large number of genes was corrected for by applying a
multiple testing correction algorithm to the observed
P-values, in this case using the Benjamini and Hochberg
method (32). Finally, microarray data of all genes,
showing signiﬁcant differential gene expression
(P< 0.01) in any condition of this and the previous experi-
ment (21) were combined and used in the down-stream
analyses. A schematic illustration of the data analysis
workﬂow is provided as supplementary ﬁgure
(Supplementary Figure S1).
Cis-regulatory element analysis
For the bioinformatics analysis of DNA cis-regulatory
elements, we ﬁrst extracted all non-overlapping gene
promoter sequences from the set of known mouse genes
at UCSC Genome Browser (33). The promoter sequences
used in the analysis spanned from 600 bp to+100 bp
relative to the annotated transcription start site (TSS).
To predict the regulatory motifs, we used the complete
collection of 639 vertebrate transcription factor-binding
site (TFBS) position weight matrices (PWMs) from
TRANSFAC (34), with thresholds PWM score 0.85
and PWM core score 0.99. Overlapping and redundant
promoters were discarded, keeping one per gene, for each
subset of regulated genes and the corresponding back-
ground. We then compared the distribution of frequencies
of predicted motifs in the subset of genes of interest with
the distribution in the rest of mouse genes using the non-
parametric Mann–Whitney–Wilcoxon test. FDR correc-
tion were applied to P-values according to the Benjamini
and Hochberg method (32). The enrichment, log2(d/b),
were deﬁned as the fold-ratio between the mean number
of sites in the subset of promoters of regulated genes (d)
and mean of the rest of mouse promoters (b). GC content
and length of promoter region together with the informa-
tion content of a motif inﬂuence the number of promoters
with putative binding sites. The fraction of promoters for
which sites are predicted and the densities per sequence are
taking into account using our methodology. The proced-
ure was performed using the R package (R Development
Core Team, 2007) and an in-house C-program, previously
used to detect enrichment of IRF sites in genes
upregulated after nerve injury (35). Signiﬁcant overrepre-
sented motifs were deﬁned as those in the subset of interest
with a minimum 2-fold enrichment, a corrected P< 0.005
and present in at least ﬁve promoters and 25% of the
promoters in the gene subset. In case of highly redundant
TRANSFAC matrices (e.g. V$NKFB_Q6_01 and
V$NFKAPPAB65_01), only the results obtained with
one of the matrices, usually the one with the lowest
P-value, are shown. The sequence logos were constructed
a posteriori using the actual content of each data set.
Immunoblot
Preparation of protein lysates, separation by SDS
polyacrylamid gel electrophoresis (SDS–PAGE), blotting
and detection by antibodies was carried out as described
previously (36): Brieﬂy, phosphate buffered saline washed
cells were lysed in RIPA-buffer [50mM Tris–HCl,
150mM NaCl, 1% (vol/vol) IGEPAL, 1% Na-
Deoxycholate (vol/vol), 0.1% (weight/vol) SDS, 1mM
dithiothreitol, 0.2mM phenylmethylsulfonyl ﬂuoride
(PMSF), 1 mg/ml leupeptin, 1 mg/ml pepstatin, 50mM
NaF, 0.1mM Na-vanadate with Complete protease in-
hibitors (Roche) (pH 7.5)]. Samples were normalized ac-
cording to Bradford protein staining, and equal amounts
were subjected to denaturing SDS–PAGE. Gels were
blotted on nitrocellulose membranes (Schleicher and
Schuell) and probed with indicated antibodies. The same
membrane was used and consecutively stripped with
reblot solution (Merck). The following commercially
available antibodies were used: a-b-actin (Sigma-
Aldrich); a-STAT1, a-Ikb-a and a-STAT2 (Santa Cruz);
phospho-Tyr-STAT1 (Cell Signaling), IRF1 (Santa Cruz)
and phosphor-Tyr-STAT2 (Millipore).
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nCounter design, measurements and data processing
To investigate the role of STAT1 on the network of IFNg-
repressed genes (IRepG), we chose 50 genes to be analysed
by nCounter technology (see Supplementary Table S3 for
complete list of genes). Details of the nCounter system are
presented in full in reference (37). We hybridized 50–
100 ng of RNA for 16 h with the code set and loaded
into the nCounter Prep Station followed by quantiﬁcation
using the nCounter Digital Analyser. Code sets were
designed and constructed to detect the 50 genes of
interest. Each code set probe matches 100 bases long
exonic sequence of the target genes (see Supplementary
Table S4 for sequences). Background correction and nor-
malization of data were performed as follows. For each
sample, the average+2 standard deviations (SDs) of back-
ground counts (negative controls) were calculated. For
each gene of each sample, the average+2 SDs were sub-
tracted from the counts. Expression of the target genes
was normalized by taking the geometric mean of the ex-
pression of the seven reference genes into account (38).
RESULTS
Combining 4sU tagging and translational arrest to dissect
IFN-mediated transcriptional regulation
To properly differentiate primary from secondary effects
and address the role of positive and negative feedback
loops, we analysed IFN-induced changes in transcription
rates in presence and absence of the translational inhibitor
CHX. NIH-3T3 cells were pre-treated with CHX for
15min (or DMSO as mock-treatment control) before
starting the 60min incubation with 100U/ml of IFNa,
IFNg and mock, respectively. During the last 30min
of IFN treatment, 4sU was added to the cell culture
medium to metabolically label newly transcribed RNA
(see Figure 1B for experimental setup). Before performing
microarray analysis, we validated the suitability of the ex-
perimental conditions. Immunoblot analyses were per-
formed to monitor the effect of IFN and CHX on
canonical IFN- and NF-kB-signalling at protein level.
As expected, following 1 h treatment, STAT1 was found
to be tyrosine phosphorylated on IFNg treatment and, to
a lesser extent, on IFNa treatment, whereas STAT2 phos-
phorylation showed the opposite regulation (Figure 1C).
Ablation of translation by CHX before IFN addition did
not prevent STAT phosphorylation. IkBa degradation, a
hallmark and a prerequisite of canonical NF-kB activa-
tion, was not observed on IFN incubation but became
weakly apparent after 75min of CHX treatment.
Induction of IRF-1 protein was more pronounced on
IFNg incubation compared with IFNa and was com-
pletely abrogated by CHX co-treatment. These results
qualiﬁed the experimental setup as model system for the
subsequent analysis of IFN signalling.
Following the experimental setup shown in Figure 1B,
total cellular RNA from the six different experimental
conditions was isolated, 4sU-tagged newly transcribed
RNA was puriﬁed and subjected to microarray analysis
using Affymetrix MG430 2.0 arrays (three biological
replicates). Data were normalized using gc-RMA, and
genes signiﬁcantly regulated (>2-fold and P< 0.01) by
either IFNa or IFNg in presence or absence of CHX
were identiﬁed. To include regulation of genes predomin-
antly affected at later times of IFN treatment (at 3 h or
150–180min), we also included the data from all genes
identiﬁed in our previous study (21) for all subsequent
analyses. This resulted in a list of 1031 probe sets signiﬁ-
cantly regulated by either IFNa or IFNg (for complete list
see Supplementary Table S1). An excellent correlation
(Pearson correlation coefﬁcient: IFNa: 0.84 and IFNg:
0.87, respectively) for both IFNa- and IFNg-mediated dif-
ferential gene expression was observed in newly
transcribed RNA at 30–60min between the previously
published and the new data set, thereby conﬁrming the
high reproducibility of this approach.
Short-term CHX treatment affects the expression of a
multitude of genes
Before having a closer look at the IFN-regulated genes, we
ﬁrst examined the effect of CHX treatment on cellular
gene expression in the absence of IFNs. In total, 343
probe sets showed differential regulation (>2-fold and
P< 0.01) on CHX treatment (Figure 2A; for complete
list of genes see Supplementary Table S2). Signiﬁcantly
more probe sets showed down-regulation (n=209) than
upregulation (n=134), consistent with a more prominent
role of short-lived activatory regulators in maintaining
steady-state transcription in comparison with inhibitory
factors. The vast majority of CHX-induced changes de-
tectable in newly transcribed RNA during 45–75min
CHX treatment were in the range of 2–20-fold.
Interestingly, with the sole exception of ‘TNF receptor-
associated factor 1’ (traf1) all transcripts showing >20-
fold induction encode canonical histones. It is well
described that CHX treatment results in signiﬁcant induc-
tion of canonical histone mRNA levels owing to alter-
ations in RNA synthesis, processing or decay (39–41).
However, the extent and the celerity of this induction
observed in newly transcribed RNA were not expected.
The relative contributions of RNA synthesis, processing
and decay can be dissected by gradually reducing the
duration of labelling (25). By shortening the duration of
4sU labeling from 30 to as little as 5min and analysing
histone RNA expression by qRT-PCR, we show this regu-
lation to be predominantly mediated by CHX-induced
changes in RNA processing rather than changes in RNA
synthesis (Supplementary Figure S2), which is consistent
with previous studies.
Cis-regulatory elements in CHX-regulated genes
Prolonged CHX treatment is known to result in NF-kB
activation owing to decay of short-lived inhibitory
proteins like Ikba, which has an intrinsic protein half-
life of 30–60min (42). To gain further insights into the
transcription factors involved in CHX-mediated differen-
tial gene expression, we performed promoter analysis
scanning for cis-regulatory elements in the proximal
promoter regions of the corresponding genes. As the prin-
ciple behind CHX-mediated induction of canonical
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histones has been shown to be histone mRNA speciﬁc and
predominantly owing to their 30-UTR resident stem-loop
structures (43), we omitted these genes from further in
silico analysis and focused on the remaining genes. We
focused on DNA motifs signiﬁcantly overrepresented
between 600 bp upstream and 100 bp downstream of the
TSS. We preformed promoter analyses using the
TRANSFAC collection of TFBS proﬁles (34).
Consistent with published data and with the reduction in
IkBa observed in our immunoblot analysis (Figure 1C),
this revealed a signiﬁcant enrichment of NF-kB sites in
genes over-expressed in the presence of CHX (33.9% of
genes, P< 5.0 108, Table 1).
Among the genes under-expressed in the presence of
CHX, we found a signiﬁcant enrichment of genes contain-
ing c-Myc/Max (43% of genes, P< 4.7 108) and E2F1
(37.3% of genes, P< 3.5 108) binding sites within their
promoter/enhancer regions (Table 1). Both are considered
to mainly fulﬁl transcriptional activator functions,
although repressive effects have been described. c-Myc/
Max is an essential heterodimeric transcription factor,
composed of the two basic helix-loop-helix zipper
proteins c-Myc and Max, which binds to E-boxes and
regulates transcription to control cell proliferation, differ-
entiation and cell death [reviewed in (44)]. E2F1 plays an
important role in cell cycle control [reviewed in (45)]. In
this context, it is noteworthy that c-Myc contains E2F-
binding sites in its promoter (46,47), indicating that
aforementioned CHX-affected gene sets are interrelated.
Our data document the transcriptional changes elicited by
CHX in absence of other stimuli owing to decay of tran-
scriptional regulators known to have short protein half-
lives, e.g. IkB-a, E2F and Myc (42,48–51).
To further substantiate the promoter/enhancer elements
enriched among genes differentially expressed in presence
of CHX, we calculated the cumulative abundance of NF-
kB, E2F and Myc/Max consensus sites within 200 bp bins
in the 20 kb upstream of the TSS of regulated genes in
comparison with upstream regions of 1000 randomly
chosen promoters. Owing to the focus of the present
study on IFN-regulated genes, we also included ISRE/
IRF and GAS consensus motifs, despite the fact that we
did not observe a signiﬁcant enrichment of these sites in
CHX-regulated genes (Figure 2B and C). To highlight the
relative enrichment, we plotted a subtraction of the
presence in regulated genes versus the presence in a set
of random genes (Figure 2C). Although the distribution
of NF-kB sites showed a peak in the 2–5 kb region
upstream of the TSS, the distribution of Myc/Max sites
and especially of E2F sites is more ﬂattened, suggesting
that the effect of these transcription factors seems to be
more far-reaching.
Negative feedback loops already dominate secondary
feedback mechanisms during the ﬁrst hour of IFN
treatment
At 30–60min, IFNa and IFNg signiﬁcantly induced ex-
pression for 179 and 399 probe sets at least 2-fold, respect-
ively (Figure 3A). CHX treatment increased the number of
IFNa-induced probe sets from 179 to 282 and IFNg from
399 to 478. In addition, it resulted in a 2.6-fold median
enhancement of probe sets already induced >3-fold by
IFNa in the absence of CHX. Interestingly, when we
compared the fold-changes induced by IFNa in absence
and presence of CHX, an almost parallel up-shift of the
linear regression line became evident, indicating that
almost all IFN-regulated probe sets are subjected to a
similar expression increase on blocked translation
(Figure 3B). This suggests a common negative feedback
mechanism requiring de novo protein synthesis, which
already dominates the secondary signalling events within
Figure 2. Changes in newly transcribed mRNAs upon inhibition of
translation. (A) Expression change (depicted in a log2-scale) of signiﬁ-
cant changes of probe sets on treatment of CHX. (B, C) Distribution
and enrichment of promoter/enhancer elements with respect to the TSS.
The upper panel (B) depicts the cumulative percentage of genes har-
bouring the indicated element in comparison with randomly chosen
gene set. The lower panel (C) depicts the enrichment in regulated
genes in comparison with 1000 randomly chosen genes by subtracting
from the curves shown in the upper panel.
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Table 1. Promoter analysis of CHX- and IFN-regulated genes
Conditions N Motif Logo Promoters
with sites
Enrichment
(d/b)
P-value
A. CHX
Genes induced by CHX (>2-fold) 62 NFkB 21 (33.9%) 4.08 5.0 108
Genes strongly induced by CHX (>5-fold) 19 NFkB 9 (47.4%) 4.72 1.5 105
Genes repressed by CHX (>2-fold) 142 Myc/Max 61 (43.0%) 2.14 4.7 108
E2F1 53 (37.3%) 2.12 3.5 108
B. IFNa
Genes induced by IFNa (>2-fold) 93 ISRE/IRF 59 (63.8%) 5.27 3.3 1045
Genes induced by IFNa (>2-fold) in the
presence of CHX
165 ISRE/IRF 87 (52.7%) 4.31 7.2 1049
GAS 49 (29.7%) 2.05 2.1 108
Genes induced by IFNa (>2-fold) and
enhanced by CHX (>2-fold)
53 ISRE/IRF 36 (67.9%) 5.61 2.4 1031
GAS 16 (30.2%) 2.04 9.4 104
Genes induced by IFNa (>2-fold) only in
the presence of CHX
18 GAS 8 (44.4%) 2.83 6.0 104
C. IFNc
Genes induced by IFNg (>2-fold) 186 GAS 63 (33.9%) 2.38 7.8 1014
ISRE/IRF 57 (30.6%) 2.48 8.6 1012
Genes induced by IFNg in the presence of
CHX (>2-fold)
271 GAS 84 (31.0%) 2.15 1.6 1014
ISRE/IRF 79 (29.2%) 2.33 8.4 1014
(continued)
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30–60min of IFNa encounter. Thus, at least one essential
component of this negative feedback mechanism requires
active translation. Among the genes induced by IFNa
in the respective time frame, we found a number of
genes that have previously been implicated in the
negative regulation of type I IFN responses, e.g. usp18
(103.9-fold induced), socs3 (4.59-fold induced), socs2
(4.19-fold induced), socs1 (2.39-fold induced) and irf2
(1.72-fold induced).
For IFNg-induced probe sets, a more complex picture
was observed. Although CHX treatment also resulted in a
noticeable, although less prominent, overall enhancement
(1.4-fold) of IFNg-induced changes, this was more het-
erogeneous than observed for IFNa and included both
enhancement and inhibition indicative of partially
opposing regulation circuits. Nevertheless, the net effect
[19.8% more genes (399 versus 478) being signiﬁcantly
induced and a median 1.4-fold increase per gene in
presence of CHX] underlines the importance of the trans-
lation-dependent negative feedback loop also for IFNg
responses (Figure 3C).
Cis-regulatory elements within IFNa-induced genes
To gain further insights into the gene expression pathways
responsible for the observed changes, we performed
promoter analysis looking for cis-regulatory elements in
the proximal promoter regions. We focused on DNA-se-
quences signiﬁcantly overrepresented from 600 bp
upstream to 100 bp downstream of the TSS. As expected
from the wealth of knowledge concerning the IFN-signal
transduction pathways, we observed ISRE/IRF sites
(STAT2:STAT1:IRF-9 or IRFs) to be signiﬁcantly
overrepresented (P=3.3 1045) among IFNa-induced
genes (n=93, 63.8% of genes with sites, see Table 1).
This was not signiﬁcantly affected by co-incubation with
CHX (52.7% of genes with sites, P=7.2 1049) consist-
ent with ISRE/IRF-signalling representing the canonical
and primary type I IFN signalling. On CHX co-treatment,
GAS (STAT-binding) sites also became signiﬁcantly
overrepresented (29.7% of genes, P=2.1 108). Most
likely, binding of STAT1:STAT1 homodimers (termed
AAF) or STAT1:STAT3 heterodimers is responsible for
this regulation. In addition, both ISRE (67.9% of genes,
P=2.4 1031) and GAS (30.2% of genes,
P=9.4 104) elements were found to be signiﬁcantly
overrepresented among genes, which were more strongly
induced on co-incubation with CHX. This indicates that
negative feedback not only shapes the quantity but also
the quality of the IFNa response.
We also observed genes induced by IFNa only in
presence of CHX but not by IFNa treatment alone.
Interestingly, the vast majority of these were not induced
even at 150–180min of sole IFN treatment, indicating that
this induction is not only due to a change in the kinetics of
gene regulation but also a bona ﬁde de-repression exerted
by CHX treatment. Interestingly, GAS sites were signiﬁ-
cantly enriched (44.4% of genes, P=6.0 104) among
these genes, hinting at a translation-dependent control
module acting on GAS-containing genes on encounter of
IFNa which requires further studies.
Table 1. Continued
Conditions N Motif Logo Promoters
with sites
Enrichment
(d/b)
P-value
Genes induced by IFNg (>2-fold) and
enhanced by CHX (> 2-fold)
50 GAS 21 (42.0%) 3.05 3.3 108
Genes induced by IFNg and more strongly
enhanced by CHX (>3-fold)
16 GAS 12 (75.0%) 5.58 4.7 1012
Genes induced by IFNg (>2-fold) and
repressed by CHX (>2-fold)
17 ISRE/IRF 7 (41.2%) 4.78 5.7 104
Genes repressed by IFNg (>2-fold) 25 G/C-rich 16 (64.0%) 2.30 3.4 103
GC-box/Sp1 17 (68.0%) 2.07 4.7 103
Over-represented cis-regulatory elements in genes showing differential expression in CHX (A), IFNa (B) and IFNg (C)-treated cells. The number of genes that fulﬁlled the
indicated conditions as well as the overrepresented transcription factor binding motifs (Logo), number of genes with sites (%), fold-ratio of mean number of sites in the data set
and the mean in the background (d/b) and Mann–Whitney–Wilcoxon test corrected P-values are shown. Please note that some ﬁgures show differentially regulated probe sets,
whereas this table depicts bona ﬁde genes; therefore, the numbers necessarily vary. See Supplementary Table S5 for further details (e.g. d and b values).
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Cis-regulatory elements within IFNc-induced genes
As expected, we found an enrichment (33.9% of genes,
P=7.8 1014) of GAS sites within the proximal
promoter regions of IFNg-induced genes (Table 1).
Similar percentages and P-values were found within
genes upregulated by IFNg in presence of CHX.
Interestingly, we also observed signiﬁcant overrepre-
sentation of ISRE/IRF sites with comparable frequencies
and P-values in the IFNg-induced genes (30.6% of genes,
P=8.6 1012), irrespective of CHX co-administration
(29.2% of genes, P=8.4 1014), indicating that ISRE/
IRF-containing genes constitute a considerable fraction of
the IFNg response. In addition, 20% of the genes
induced by IFNg, irrespective of the presence of CHX,
harbour an ISRE/IRF element but no GAS site (within
the assessed promoter/enhancer region), arguing against
‘hitchhiker’ effects as the sole explanation for this obser-
vation. This is consistent with previous data on STAT2
phosphorylation and ISGF3 activation in response to
IFNg (8,9,52). On the other hand, ISRE/IRF sites were
found to be the only signiﬁcantly overrepresented
elements (41.2% of genes, P=5.7 104) in the genes
that showed reduced induction by IFNg on CHX co-treat-
ment. Therefore, the ISRE/IRF-response at 30–60min of
IFNg treatment most likely constitutes a composite
response, which both includes direct induction via
ISGF3 (induced irrespective of CHX and repressed by
translation dependent negative feedback mechanisms) as
well as translation-dependent signalling mediated by, for
example, IFNg-induced IRF proteins like IRF-1 thereby
at least partially explaining the more diverse effects of
CHX on the IFNg-induced genes.
Figure 3. Negative feedback mechanisms dominate early IFN responses. (A) Differential regulation by IFNa (light grey) or IFNg (dark grey) at
indicated time points. Each signiﬁcantly regulated probe set is represented by a dot. (B, C) Effect of CHX on IFN-mediated differential gene expression.
The correlation of changes in gene expression in between genes regulated in absence (x-axis) or presence of CHX (y-axis) by either IFNa (B) or IFNg
(C) are depicted in a log2-scale. The insert displays the number of genes and the fold increase (median) owing to inhibition of translation.
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Temporal changes and stringency in occupancy of cis-
regulatory elements
We assessed the frequency of genes with a given induction
strength (21 -, 22 -, 23 - or 24-fold induced) at a given time
interval post IFN treatment containing either ISRE or
GAS sites (Figure 4A and B). Although we did not ﬁnd
a signiﬁcant enrichment of NF-kB motifs within ISGs, we
included NF-kB as control owing to its prominent role in
innate immune signalling and its previously described im-
plication in IFN signal transduction (53). When looking at
genes induced >2-fold by IFNa, we found, irrespective of
the labelling interval, 60% of genes to harbour ISRE/IRF
sites. Only 20–30% of genes contained GAS sites and
<20% contained NF-kB sites (Figure 4A). The stronger
genes were induced by IFNa within the ﬁrst 30min, the
higher was the likelihood to ﬁnd ISRE/IRF sites,
culminating in the ﬁnding that 100% of genes induced
>8-fold within the ﬁrst 30min contained ISRE/IRF
elements (Figure 4A). This indicates that strong and
rapid induction by IFNa can be sufﬁciently explained by
the presence of ISRE/IRF sites within the proximal
promoter/enhancer region.
In >2-fold IFNg-induced genes, we found enrichment
of ISRE/IRF and GAS sites with similar percentages (30–
40%) (Figure 4B). These percentages increased to 70–80%
in genes induced more vigorously by IFNg (>8 - or even
>16-fold) within the ﬁrst 30min of IFNg treatment but
did not reach 100% as observed for the most strongly
IFNa-induced genes (Figure 4B). Interestingly, strongly
IFNg-induced genes showed a motif changeover during
on-going IFNg treatment with the percentage of genes
harbouring a GAS site gradually decreasing from >70%
(0–30min) to <33% (150–180min). In contrast, the per-
centage of genes with an ISRE/IRF site slightly increased
from 50 to 65%. This suggests a temporal change in the
transcriptional program during IFNg treatment from an
immediate-early GAS-response towards a secondary
ISRE/IRF-mediated response later on, likely due to the
second wave of regulation mediated by transcription
factors like IRF-1.
Cooperative effects of ISRE/IRF and GAS sites
When we divided genes in classes depending on the
number of ISRE/IRF elements, we observed that genes
harbouring an ISRE/IRF element in their proximal
promoter regions are more strongly induced upon IFNa
than those lacking an ISRE/IRF element and that genes
harbouring more than one ISRE/IRF site are also more
strongly induced by IFNa compared with genes with only
one element (Figure 4C; P< 0.00029). The same was
observed for the genes induced by IFNa in presence of
CHX; P=9.2 106). This suggests an additive and co-
operative nature of ISRE/IRF-E elements. A biochemical
counterpart to this observation has been made previously
(54). Among IFNg-induced genes, we also observed an
increased induction of genes harbouring more than one
ISRE/IRF site within their proximal promoter region
(Figure 4D)—although this was less pronounced in
terms of signiﬁcance (P< 0.019) and intensity. GAS sites
within IFNa-induced genes did not show such a trend.
However, the number of IFNa-inducible genes containing
more than one GAS site was only low (n=2).
To exclude the possibility that regulation via ISRE/IRF
sites might simply mask cooperative effects of GAS sites,
we had a closer look at IFNg-inducible genes, which lack
ISRE/IRF sites but harbour no, one, or more than one
GAS site within their promoter/enhancer elements, re-
spectively. Interestingly, we found that GAS sites seem-
ingly act cooperatively on IFNg and CHX co-treatment
but not on IFNg-treatment alone (Supplementary Figure
S3), which might indicate that negative feedback-loops
mask such additive effects on promoters containing
multiple GAS sites.
Cis-regulatory elements in distal promoter regions
Although the majority (>70%) of IFNa-induced changes
can likely be attributed to ISRE/IRF and GAS sites
present in proximal promoter regions (PPR, 600 to
+100 bp from TSS) about half of the IFNg-induced
genes had no ISRE/IRF, GAS or NF-kB sites in their
PPR. As we did not ﬁnd any additional signiﬁcantly
overrepresented motif available in the TRANSFAC
database in the PPR, we extended our promoter analysis
to look for ISRE/IRF, GAS or NF-kB sites as far as 20 kb
upstream of the TSS. The proportion of promoters that
had at least one of the motifs at a given distance for IFNa-
and IFNg-induced genes compared with non-induced
genes is depicted in Figure 5. After subtracting the back-
ground signal, it can be clearly appreciated that the
strongest signal for ISRE and GAS is located in the
PPR. Compared with promoters of IFNa-induced genes,
promoters of IFNg-induced genes showed a less
pronounced accumulation of ISRE motifs but a stronger
accumulation of GAS sites.
The network of IRepG constitutes a primary IFN
response
As stated earlier in the text, IFNg is capable to repress the
expression of a set of genes (21). We were therefore inter-
ested to test whether this response constitutes a primary or
secondary response to IFNg. We found the majority of the
80 probe sets described to be repressed by IFNg to be
also >1.5-fold downregulated on IFNg treatment in our
current experiments (Figure6A). Most importantly, 35 of
38 probe sets, which showed >2-fold repression in both
the old and new experiment by IFNg treatment alone,
were also >2-fold repressed by IFNg in presence of
CHX. This ﬁnding excludes the necessity of de novo
protein translation for this transcriptional repression and
reveals a direct role of IFNg-signalling in transcriptional
repression. Therefore, this gene family comprises genuine
IRepGs. Expression of these probe sets was not generally
repressed by CHX treatment alone (median regulation by
CHX alone=1.2-fold upregulation). Most interestingly,
the number of signiﬁcantly repressed probe sets even
increased from 62 to 94 on CHX addition, suggesting
that IFN-induced gene repression is also under the
control of a rapid translation-dependent negative
feedback mechanism.
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Figure 4. Temporal resolution (A, B) and co-operative nature (C, D) of TFBS enrichment in relation to transcriptional changes. (A) Percentage of
genes harbouring an ISRE/IRF (white bars), a GAS (grey bars) or an NF-kB (black bars) element on IFN incubation within the indicated time
frame (0–30, 0–60, 30–60 and 150–180min of IFNa incubation, respectively) in respect to the individual strength of induction (more than two-, four-,
eight- and 16-fold). (B) The same ﬁgure as in A, but for IFNg. The median fold induction (depicted in a log2-scale) for IFNa- (C) and IFNg-induced
genes (D) is shown in respect to the number of ISRE/IRF or GAS elements in their promoter/enhancer (0, 1 or >1) on IFN incubation in absence
(upper panel) or presence (lower panel) of CHX. The P-value of the correlation between number of sites and induction is indicated in the diagrams.
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Cis-regulatory elements within IRepGs
IRepGs did not show any signiﬁcant enrichment of GAS
or ISRE/IRF sites. Nevertheless, these gene-repressions
even occurred in presence of CHX, thus constituting a
bona ﬁde primary IFNg response. The absence of GAS
and ISRE elements in their proximal promoter regions is
consistent with the well-established role of ISGF3 and
GAF in induction but not suppression of transcription.
Interestingly, we found a signiﬁcant overrepresentation
(64.0% of genes, P< 3.4 103) of G/C-rich promoter/
enhancer elements and corresponding SP1/SP3-DNA
binding sites, so called GC-boxes (68.0% of genes,
P< 4.7 103, see Table 1). We observed a gradual en-
richment of SP1/SP3 sites and even more frequent of G/C-
rich stretches near the TSS (Figure 5E and F).
For an individual IRepG (‘lipoprotein lipase’), negative
regulation by SP1 and SP3 has been described (55). Our
data imply that such regulation is more widespread than
commonly accepted and thus deserves a thorough investi-
gation concerning the underlying receptor-proximal
events and contribution to antiviral, anti-pathogenic and
anti-tumorigenic IFNg functions.
IFNc-mediated repression depends on STAT1
Although the prominent role of STAT1 for IFNg is well
established, disagreement exists concerning the relevance
of STAT1 for IFNg-induced gene repression (56,57).
To clarify this issue, we used STAT1-deﬁcient ﬁbroblasts
(26) and used Nanostring nCounter technology for
accurate multiplex measurements of transcripts of 50
genes (19 IRepGs, 10 house-keeping genes, 12 IFNg-
induced genes as well as 9 gene products involved in ca-
nonical IFN-signalling, see Supplementary Table S3 for
complete list of genes). Both STAT1-expressing and
STAT1-deﬁcient ﬁbroblasts were treated with either
IFNg or mock for 60min as described in Figure 1B and
newly transcribed RNA was puriﬁed. RNA samples
derived from two independent experiments (two biological
replicates/experiment) were analysed. Data were
normalized according to the seven most stable house-
keeping genes. Two genes (ifna4 and ifna6) were not de-
tectable by the NCounter probes and thus excluded from
the analysis.
In agreement with the central role of STAT1 for
IFNg signal transduction, strong induction of the 12
Figure 5. Positional distribution of TFBS. Distribution and enrichment of elements [ISRE/IRF (orange), GAS (light blue), NF-kB (green), SP1/SP3
(dark blue) and G/C-rich (grey)] in respect to the TSS for IFNa-induced (A, B), IFNg-induced (C, D) and IFNg-repressed (E, F) genes. Curves
derived from regulated genes are shown as straight lines and the non-regulated control genes are depicted as dotted lines. The Upper panel (A, C, E)
shows the additive percentage of genes harbouring the indicated element in comparison with randomly chosen gene set. The lower panel (B, D, F)
depicts the over-representation of elements in the regulated genes in comparison to the non-regulated genes by subtracting of the curves shown in the
upper panel.
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IFNg-inducible genes was observed in normal but not in
STAT1/ ﬁbroblasts (see Supplementary Figure S4).
Consistent with our previous data, IFNg treatment
resulted in signiﬁcantly reduced transcript levels for 17/
19 (89%) of the IRepGs in STAT1-expressing ﬁbroblasts
(Figure 6B). Interestingly, this repression was not detect-
able in the STAT1-deﬁcient ﬁbroblasts where only three
genes showed >20% repression (Fisher’s exact test:
P< 0.0001). Although the IFNg-induced repression was
less prominent than observed by microarrays, these data
reveal IFNg-mediated repression to depend on STAT1.
Next, we compared expression levels of the 48 genes in
IFN-naı¨ve cells (Figure 6C). Interestingly, basal expres-
sion levels of 11/19 (58%) IRepGs were strongly
dependent on the presence of STAT1, whereas STAT1
was only required for 2/21 (9%) of the class of IFN-
induced genes in absence of IFNg (Fisher’s exact test:
P=0.0019), namely, tap1 and tap2. These data indicate
a previously unsuspected role of alternative STAT1
complexes in maintaining basal expression levels of
IRepGs requiring further studies.
IFNc-mediated gene repression occurs in murine bone
marrow-derived primary macrophages
IRepGs are characterized by a shorter median RNA half-
life (median t½=90min) than mouse transcripts in
general (median t½=295min) (21). Based on this short
half-life, we hypothesized that their regulation should
Figure 6. IFNg-mediated gene repression depends on STAT1. (A) Comparison of genes repressed by IFNg (30–60min) in presence (y-axis) and
absence (x-axis) of CHX. The number of regulated genes within the rectangles illustrated in different grey scales are indicated. (B, C) nCounter
analysis of the effect of IFNg on 50 marker genes in NIH-3T3 and STAT1/ ﬁbroblasts. Cells were treated with 100U/ml of IFNg or mock for
60min. In all, 500mM 4sU was added from 30 to 60min of treatment. Newly transcribed RNA was puriﬁed and subjected to nCounter measure-
ments for transcripts of 50 selected genes. Data were normalized based on seven house-keeping genes showing stable expression levels in both cell
lines. For 19 IRepGs (B), combined data from two independent experiments, consisting of two biological replicates are shown. Although expression
of 17/19 IRepGs was observed in NIH-3T3, only 4/19 genes showed >20% reduced expression levels in the STAT1/ cells (Fisher’s exact test:
P< 0.0001). (C) Dependency of gene expression on STAT1 in IFNg-naı¨ve cells. nCounter measurements of basal expression levels in NIH-3T3 and
STAT1/ ﬁbroblasts are shown. Expression of 11/19 (58%) of the IRepGs but only two of the 21 other genes (9%) was dependent on STAT1
(Fisher’s exact test: P=0.0019).
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become detectable in total RNA. To assess the conserva-
tion and extent of regulation of IRepGs in another cell
type considered more relevant to innate immunity, we
took advantage of a comprehensive set of data analysing
IFNg-induced changes in total RNA levels in murine bone
marrow-derived primary macrophages (BMDMs)
obtained by the Ghazal laboratory (58). In this data set,
IFNg-induced changes in mRNA expression levels were
determined in 30min intervals for a 12 h period using
Mouse Agilent V2 arrays. Interestingly, the vast
majority of IRepGs, we identiﬁed in ﬁbroblasts also
showed signiﬁcant downregulation in BMDMs between
150 and 210min post-treatment (Figure 7). Therefore,
regulation of IRepGs is not restricted to ﬁbroblasts. The
temporal delay highlights the difference in sensitivity for
analysing short-term changes in gene expression in newly
transcribed compared with total cellular RNA. This
provides strong evidence that the respective RNA tran-
scripts are also short-lived in primary murine macro-
phages. In addition, their regulation appears to be
subject to similar negative feedback regulation as
observed in ﬁbroblasts. In conclusion, IRepGs represent
a group of genes with regulatory functions involved in
regulation of gene expression, cellular development, cell
death and cellular growth and proliferation transiently re-
pressed during the ﬁrst few hours of the IFNg response.
DISCUSSION
In this study, we combined transcriptomics of nascent
RNA (4sU tagging) with short-term translational inhib-
ition using CHX to study the kinetics and molecular
mechanisms of IFN-mediated differential gene expression.
Inhibition of protein synthesis using CHX is a commonly
used approach to dissect translation-dependent from
translation-independent changes in gene expression. As
changes in gene expression following a stimulus generally
take 3–6 h to become apparent in total RNA for the
majority of genes, prolonged translational arrest is
required to elucidate the nature of the observed changes.
4sU tagging provides quantitative data on the kinetics of
transcriptional changes in a time scale of 30min (21),
thereby detailing the real-time kinetics of transcription
factors activity. So far, the power of the two approaches
has never been combined. In the present study, we used
4sU tagging, short-term CHX-treatment and in silico
promoter analysis to depict the real-time contribution of
feedback mechanisms during the ﬁrst hour of the response
of ﬁbroblasts to type I and II IFNs.
Interestingly, differential gene expression caused by
both IFNa and IFNg treatment was signiﬁcantly
enhanced on ablation of translation by CHX, revealing
a dominant global role of negative feedback loops
already within the ﬁrst hour of treatment. Of note, al-
though CHX treatment resulted in a uniform enhance-
ment of the IFNa-induced genes by 3-fold, its effect
on IFNg-regulated was more diverse, indicating a
greater contribution of positive feedback loops, e.g.
mediated by induction of IRF-1, during the ﬁrst hour of
IFNg treatment. Translation-dependent negative feedback
loops dominating early IFN responses have been
described for individual genes [ISG54 (59), IFN-IND1
and IFN-IND2 (60)] in human melanoma cells and
human diploid ﬁbroblasts. Nevertheless, it will be import-
ant to extend this kind of analysis to other cell types and
to different species (especially humans) to evaluate
whether the dominance of rapid negative feedback regu-
lation constitutes a general feature of the IFN response.
Positive feedback loops may well play a more important
role in immunologically more active cells, e.g. macro-
phages or dendritic cells. For individual genes, enhanced
induction on CHX co-treatment has been reported. As
such, CHX ‘supra-induces’ ISG54 mRNA amounts (59)
and increases mRNA levels of IFN-IND1 and IFN-IND2
(60). However, the well-known anti-proliferative and even
pro-apoptotic nature of IFNs suggests that rapidly
activated inhibitory regulative circuit alleviate detrimental
effects of IFN-regulated genes. This is exempliﬁed by the
fatal effect of IFNg in SOCS1-deﬁcient mice (61).
Nevertheless, it is tempting to speculate that (some) cells
might be equipped to de-repress this rapid negative regu-
lation under particular situations, e.g. when additional in-
ﬂammatory stimuli (e.g. toll-like receptor, NOD-receptor,
RIG-like receptor co-engagement or TNF-stimulation)
are encountered.
Among IFN-induced genes, we found a signiﬁcant en-
richment of ISRE/IRF consensus elements and GAS sites.
As expected, IFNa-induced genes were characterized by
the presence of ISRE/IRF elements. On co-administration
of CHX and IFNa, GAS sites become more strongly
enriched, suggesting that a translation-dependent control
element shapes the quality of the type I IFN response.
IFNg-induced genes either contain GAS or ISRE/IRF
elements, irrespective of the presence of CHX. The enrich-
ment of ISRE/IRF containing promoters, even in the
absence of translation, is consistent with a direct role of
STAT2 in IFNg signalling (8,9,62). Consistently, a novel
subset of genes induced by IFNg containing ISRE and kB
motifs within their promoters and critically requiring the
inhibitor of kB kinase beta (IKKb) has recently been
described (63).
Apart from JAK-STAT pathways, IFNs initiate a
variety of other signal transduction modules, e.g.
mitogen-activated protein kinase, phosphatidylinositol-3-
kinase, calcium-calmodulin-dependent protein kinase II,
PK-C, cJUN and others (64,65). With the sole exception
of transcription factors recognizing DNA motifs
overlapping with ISRE/IRF or GAS sites (e.g. AREB6),
which we consider to mainly constitute ‘hitchhikers’, we
did not observe any other known DNA-binding motifs of
other transcription factors included in the TRANSFAC
database or random hexanucleotide sequences to be sig-
niﬁcantly enriched among IFN-induced genes (data not
shown). Only STAT and IRF proteins left an obvious
and signiﬁcant footprint during the ﬁrst hour of IFN
treatment. Attempting to identify further enriched
elements, we conducted a motif discovery approach
(MEME), which yielded only one additional signiﬁcantly
enriched motif, which consists of three GAAA stretches
(data not shown). A similar extended ISRE element (con-
taining three AAA elements—two of them GAAA) was
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recently shown to mediate the IRF-1-dependent TRIM22
induction by IFNg (66). Additionally, independent IRF-1
ChIP-seq studies revealed the importance of this motif
(67). This total dependence of IFN responses on STAT
and IRF proteins is consistent with the total absence of
ISG expression and antiviral activity of IFNa and IFNg in
cells derived from STAT1-deﬁcient mice (26,68).
The role of IFNg in transcriptional repression is only
partially understood. This is due to the insufﬁcient
temporal resolution and sensitivity of current standard
Figure 7. Transient down regulation of IRepGs in primary mouse bone marrow derived macrophages. In a recently published study (58), mouse
BMDM were treated with 10U/ml IFNg. Cells were lysed with Trizol every 30min during the ﬁrst 12 h of treatment and the obtained RNA samples
were hybridized to Mouse Agilent V2 arrays. Gene probes matching to the list of IRepGs we identiﬁed in murine ﬁbroblasts were identiﬁed and ‘per
gene normalized’ values were calculated from log2 expression values. (A) Heat map of ‘per gene normalized’ log2 expression values over the 12 h time
course post-treatment (p.t.) are shown. Gene probes were clustered by Euclidean distance (Yellow—upregulated, Blue—downregulated). (B) Line
graph of mean per gene normalized log2 expression values. The arrow indicates the time point showing the strongest down regulation.
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technologies (like microarray studies on total RNA) to
identify such negative gene regulation when using total
cellular RNA. In contrast, 4sU tagging is especially
powerful for unmasking these rapid repressive changes
in gene expression. We observed IFNg-mediated repres-
sion to be dependent on STAT1 and subjected to negative
feedback mechanisms similar to IFNg-induced changes. In
accordance with our ﬁndings in mouse ﬁbroblasts, a strik-
ingly similar IFNg-dependent repression (CHX-resistant
and STAT1-dependent) has been reported for the
COL2A1 gene in human chondrocytes, whose promoter
does not harbour GAS sites but GC-rich elements (57),
suggesting this type of regulation also to be present in
human cells.
The biological role of IFNg-induced gene repression in
terms of anti-pathogenic, anti-proliferative and immune-
stimulatory function remains to be determined.
Nevertheless, based on the annotations of the IRepGs, it
is tempting to speculate on potential implications of their
repression. It is well-described that several components of
IFN induction and signalling are themselves IFN-indu-
cible (see earlier in the text). Conversely, several of the
IRepGs (e.g. Dusp1, Dusp10, Hes1) have been previously
shown to constitute key negative regulators of innate
immune responses and cytokine induction like p38 activa-
tion, IL-6 induction and Jak-STAT signalling (69–74).
Their repression may thus aid and modulate the establish-
ment of a transient state of hyper alertness for innate
immunity related stimuli. Most of the IRepGs encoded
transcripts are rather short-lived (median t½=90min).
This is highly characteristic for genes with key regulatory
functions, e.g. transcription factors and genes involved in
cell signalling (75). IRepGs are thus likely to represent
important regulators of the innate immune response. As
we observed repression of IRepGs in both murine ﬁbro-
blasts and primary macrophages, their regulation repre-
sents a core component of the primary IFNg response.
Interestingly, expression of more than half of the
IRepGs showed a strong dependency on STAT1 in IFN-
naı¨ve cells. Even though these results were obtained from
two different ﬁbroblast cell lines, i.e. NIH-3T3 ﬁbroblasts
and immortal STAT1/ ﬁbroblasts, it may indicate a
dual role of STAT1 in mediating both rapid stimulation
of IFN-inducible genes by STAT1-homodimers and main-
taining basal expression levels of other genes, presumably
constituted by different STAT1-protein complexes. In this
respect, it is tempting to speculate that the IFNg-mediated
repression is due to a deprivation of these alternative
complexes of STAT1 by the robust IFNg-mediated
STAT1 phosphorylation. It has recently been established
that STAT1 dimers change their conformation on IFNg-
induced activation from an antiparallel to a parallel state
(76,77), which might instruct such deprivation processes.
How this correlates to the overrepresentation of GC-rich
elements and putative SP1/SP3 binding sites in their
proximal promoter regions remains to be elucidated.
Further studies are required to clarify this interesting
observation.
As expected, 75min of CHX treatment resulted in sub-
stantial alterations in gene expression. Transcriptional re-
pression was more frequent than induction, which reﬂects
rapid decay of short-lived transcription factor proteins or
their regulatory proteins during translational arrest.
Within the CHX-induced genes, we detected signiﬁcant
overrepresentation of NF-kB sites consistent with prefer-
ential loss of the rather short-lived IkBa protein and sub-
sequent activation of NF-kB signalling. CHX-repressed
genes were characterized by an enrichment of Myc/Max
and E2F-binding sites, both of which are known for their
short protein half-life. Interestingly, we found that CHX
treatment altered transcription rates of many genes
implicated in the regulation of TNF signalling and
known to be important for cell survival in the presence
of TNF. As such, the abundance of traf1, A20/Tnfaip3,
rel-b, c-Flip and IB transcripts was induced, whereas
caspase 3, traf4 and sphingosin kinase, were signiﬁcantly
repressed. TNF is known to induce rapid activation of
NF-B by inducing a phosphorylation-dependent
ubiquitination and proteasomal degradation of IB,
which otherwise sequesters p50:p65 heterodimers from
transcriptional activity (78,79). In the absence of cellular
gene expression, for example in presence of CHX or
actinomycin D, TNF turns into a highly potent pro-apop-
totic signal, thereby leading to cell death (80,81).
Conversely, if TNF is added to cells that are able to
induce NF-kB target gene expression, apoptosis is not
initiated. Therefore, NF-kB signalling can be considered
as a cell-intrinsic monitoring module to check for gene
expression competence (82–84). We were surprised to
ﬁnd that CHX-incubated cells upregulate negative
NF-kB signalling molecules and downregulate positive
regulators of TNF signal transduction. This suggests
that similar mechanisms might act during incomplete or
transient blockade of translation to prepare for TNF en-
counter in an attempt to increase chances of survival. In
summary, these results highlight the need to restrict the
duration of translational arrest to avoid secondary effects
on the biological mechanisms under study. However,
various viruses induce a host cell shut-off, for example,
by interfering with cap-dependent translation. Therefore,
the transcriptional responses elicited by IFNs during im-
pairment of translation might also be of biological
relevance.
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